Clinical Trials Logo

OCD clinical trials

View clinical trials related to OCD.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04461730 Withdrawn - Parkinson Disease Clinical Trials

Role of Basal Ganglia and Thalamus in Perceptual Consciousness and Metacognition

METACTION
Start date: December 2021
Phase:
Study type: Observational

The term perceptual awareness refers to subjective experience... or the phenomenology associated with the processing of a sensory stimulus. The term metacognition refers to our ability of introspection, knowledge and control of our own cognitive processes. The objective of this research is to establish the contribution of the basal ganglia and thalamus to the perceptual awareness and meta-cognition, using deep brain stimulation coupled with electroencephalography.

NCT ID: NCT03926546 Withdrawn - OCD Clinical Trials

Individual Versus Group Exposure With Response Prevention (ERP) for the Treatment of Obsessive Compulsive Disorder (OCD)

Start date: May 2020
Phase: N/A
Study type: Interventional

The primary objective is to examine the efficacy of implementing evidence based Exposure and Response Prevention (ERP) within group therapy versus individual therapy by monitoring reduction of Obsessive-Compulsive Disorder (OCD) symptomology.

NCT ID: NCT03842345 Withdrawn - Healthy Clinical Trials

DELPhI Evaluation of Psychiatric Conditions

Start date: March 2020
Phase:
Study type: Observational

DELPhI acquisition and analysis software, a QuantalX Neuroscience development, which is designed to measure, analyze, and display brain electrical activity of human electroencephalogram (EEG), to transcranial magnetic stimulation (TMS), will be used to evaluate different psychiatric conditions.

NCT ID: NCT00399022 Withdrawn - OCD Clinical Trials

Treatment With Duloxetine for OCD Patients

Start date: n/a
Phase: N/A
Study type: Interventional

Testing the efficacy of the SNRI medication Duloxetine for treating OCD patients who did not respond to SSRI